Summary

Ischemia Reperfusion Injury Treatment Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Ischemia Reperfusion Injury Treatment offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Indication:

• Heart injury
• Kidney injury
• Intestine injury
• Other injury

By End-User:

• Hospitals
• Specialty Clinics

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Report Chapters

Executive Summary

The executive summary of the Ischemia Reperfusion Injury Treatment Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Ischemia Reperfusion Injury Treatment Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Ischemia Reperfusion Injury Treatment Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Indication processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Ischemia Reperfusion Injury Treatment Market Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (US$ 823.74 Million) analysis (2018-2022) and current and future market value (US$ 873.98 Million) and volume (6.1%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Ischemia Reperfusion Injury Treatment Market - Pricing Analysis

Based on By Indication, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033, By Indication

Based on By Indication, Ischemia Reperfusion Injury Treatment Market is segmented into Heart injury, Kidney injury, Intestine injury, Other injury. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication.

Chapter 06 - Global Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033, By End-User

Based on By End-User, Ischemia Reperfusion Injury Treatment Market is segmented into Hospitals, Specialty Clinics. This section also offers market attractiveness analysis based on By End-User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-User.

Chapter 07 - Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Ischemia Reperfusion Injury Treatment Market is segmented into North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 08 - North America Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 09 - Latin America Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Ischemia Reperfusion Injury Treatment Market in the Latin America region.

Chapter 10 - Europe Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Ischemia Reperfusion Injury Treatment Market in the regional market.

Chapter 11 - East Asia Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Ischemia Reperfusion Injury Treatment Market in the regional market.

Chapter 12 - South Asia Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Ischemia Reperfusion Injury Treatment Market in the regional market.

Chapter 13 - Middle East and Africa Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Ischemia Reperfusion Injury Treatment Market in the regional market.

Chapter 14 - Key Countries Ischemia Reperfusion Injury Treatment Market Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Ischemia Reperfusion Injury Treatment Market is expected to grow in major countries globally.

Chapter 15 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 16 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Indication portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Amyndas Pharmaceuticals LLC, Angion, Bolder Biotechnology, Opsona Therapeutics Ltd., Pharming Group NV, Prolong Pharmaceuticals, Prothix BV, Stealth BioTherapeutics, Inc., Zealand Pharma A/S, Faraday Pharmaceuticals, SBI Pharmaceuticals.

Chapter 17 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 18 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Ischemia Reperfusion Injury Treatment Market.

ページTOPに戻る

Table of Contents

1. Executive Summary | Ischemia Reperfusion Injury Treatment Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Indication

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

5.3.1. Heart Injury

5.3.2. Kidney Injury

5.3.3. Intestine Injury

5.3.4. Other Injury

5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 022

5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

6. Global Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Treatment

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 022

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033

6.3.1. Drug Therapy

6.3.2. Medicated Gases

6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 022

6.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033

7. Global Market Analysis 2018 to 022 and Forecast 2023 to 2033, By End-user

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By End-user, 2018 to 022

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user, 2023 to 2033

7.3.1. Hospitals

7.3.2. Specialty Clinics

7.4. Y-o-Y Growth Trend Analysis By End-user, 2018 to 022

7.5. Absolute $ Opportunity Analysis By End-user, 2023 to 2033

8. Global Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 022

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. South Asia

8.3.5. East Asia

8.3.6. Oceania

8.3.7. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Indication

9.2.3. By Treatment

9.2.4. By End-user

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Indication

9.3.3. By Treatment

9.3.4. By End-user

9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Indication

10.2.3. By Treatment

10.2.4. By End-user

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Indication

10.3.3. By Treatment

10.3.4. By End-user

10.4. Key Takeaways

11. Europe Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. United kingdom

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Europe

11.2.2. By Indication

11.2.3. By Treatment

11.2.4. By End-user

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Indication

11.3.3. By Treatment

11.3.4. By End-user

11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Malaysia

12.2.1.3. Singapore

12.2.1.4. Thailand

12.2.1.5. Rest of South Asia

12.2.2. By Indication

12.2.3. By Treatment

12.2.4. By End-user

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Indication

12.3.3. By Treatment

12.3.4. By End-user

12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Indication

13.2.3. By Treatment

13.2.4. By End-user

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Indication

13.3.3. By Treatment

13.3.4. By End-user

13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.1.1. Australia

14.2.1.2. New Zealand

14.2.2. By Indication

14.2.3. By Treatment

14.2.4. By End-user

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Indication

14.3.3. By Treatment

14.3.4. By End-user

14.4. Key Takeaways

15. MEA Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 022

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Indication

15.2.3. By Treatment

15.2.4. By End-user

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Indication

15.3.3. By Treatment

15.3.4. By End-user

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2022

16.1.2.1. By Indication

16.1.2.2. By Treatment

16.1.2.3. By End-user

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2022

16.2.2.1. By Indication

16.2.2.2. By Treatment

16.2.2.3. By End-user

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2022

16.3.2.1. By Indication

16.3.2.2. By Treatment

16.3.2.3. By End-user

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2022

16.4.2.1. By Indication

16.4.2.2. By Treatment

16.4.2.3. By End-user

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2022

16.5.2.1. By Indication

16.5.2.2. By Treatment

16.5.2.3. By End-user

16.6. United kingdom

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2022

16.6.2.1. By Indication

16.6.2.2. By Treatment

16.6.2.3. By End-user

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2022

16.7.2.1. By Indication

16.7.2.2. By Treatment

16.7.2.3. By End-user

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2022

16.8.2.1. By Indication

16.8.2.2. By Treatment

16.8.2.3. By End-user

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2022

16.9.2.1. By Indication

16.9.2.2. By Treatment

16.9.2.3. By End-user

16.10. India

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2022

16.10.2.1. By Indication

16.10.2.2. By Treatment

16.10.2.3. By End-user

16.11. Malaysia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2022

16.11.2.1. By Indication

16.11.2.2. By Treatment

16.11.2.3. By End-user

16.12. Singapore

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2022

16.12.2.1. By Indication

16.12.2.2. By Treatment

16.12.2.3. By End-user

16.13. Thailand

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2022

16.13.2.1. By Indication

16.13.2.2. By Treatment

16.13.2.3. By End-user

16.14. China

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2022

16.14.2.1. By Indication

16.14.2.2. By Treatment

16.14.2.3. By End-user

16.15. Japan

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2022

16.15.2.1. By Indication

16.15.2.2. By Treatment

16.15.2.3. By End-user

16.16. South Korea

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2022

16.16.2.1. By Indication

16.16.2.2. By Treatment

16.16.2.3. By End-user

16.17. Australia

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2022

16.17.2.1. By Indication

16.17.2.2. By Treatment

16.17.2.3. By End-user

16.18. New Zealand

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2022

16.18.2.1. By Indication

16.18.2.2. By Treatment

16.18.2.3. By End-user

16.19. GCC Countries

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2022

16.19.2.1. By Indication

16.19.2.2. By Treatment

16.19.2.3. By End-user

16.20. South Africa

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2022

16.20.2.1. By Indication

16.20.2.2. By Treatment

16.20.2.3. By End-user

16.21. Israel

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2022

16.21.2.1. By Indication

16.21.2.2. By Treatment

16.21.2.3. By End-user

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Indication

17.3.3. By Treatment

17.3.4. By End-user

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Amyndas Pharmaceuticals LLC

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Angion

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Bolder Biotechnology

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. Opsona Therapeutics Ltd.

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Pharming Group NV

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. Prolong Pharmaceuticals

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. Prothix BV

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Stealth BioTherapeutics, Inc.

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. Zealand Pharma A/S

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. Faraday Pharmaceuticals

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.11. SBI Pharmaceuticals

18.1.11.1. Overview

18.1.11.2. Product Portfolio

18.1.11.3. Profitability by Market Segments

18.1.11.4. Sales Footprint

18.1.11.5. Strategy Overview

18.1.11.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology